Pharma & Healthcare
Global Human Rabies Immunoglobulin (IM) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Apr 16, 25
- ID: 198350
- Pages: 96
- Figures: 99
- Views: 2
The global Human Rabies Immunoglobulin (IM) market size was US$ 327 million in 2024 and is forecast to a readjusted size of US$ 407 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure. Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization. In this report, we study ERIG (Equine Rabies Immunoglobulin) and HRIG (Human Rabies Immunoglobulin)
The rising incidence of rabies, especially in developing countries, is a key driver of the human rabies immunoglobulin market. Rabies remains a significant public health concern, particularly in regions where animal vaccination programs are insufficient. Post-exposure prophylaxis (PEP), which includes human rabies immunoglobulin, is critical for preventing the virus after a bite from a rabid animal. Increasing awareness of rabies prevention, government initiatives, and partnerships with international health organizations have boosted demand for human rabies immunoglobulin in both rural and urban areas.
A major challenge in the human rabies immunoglobulin market is its limited availability and high cost, particularly in low- and middle-income countries where rabies is most prevalent. The production of immunoglobulins requires advanced technology and biological materials, making it costly and sometimes scarce in regions with insufficient healthcare infrastructure. Additionally, the need for timely administration after exposure poses logistical difficulties, especially in remote areas, where access to healthcare facilities may be delayed, potentially limiting the effectiveness of the treatment.
Asia-Pacific is expected to experience the highest growth in the market during the forecast period.
The global Human Rabies Immunoglobulin (IM) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
CSL Behring
Grifols
Sanofi
Sichuan Yuanda Shuyang
Tiantan Bio
Kamada
CBPO
Shuanglin Bio
Weiguang Bio
Shanghai RAAS
Bharat Serum
VINS
By Type: (Dominant Segment vs High-Margin Innovation)
ERIG
HRIG
By Application: (Core Demand Driver vs Emerging Opportunity)
Category II Exposure
Category III Exposure
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., CSL Behring in Europe)
- Emerging Product Trends: ERIG adoption vs. HRIG premiumization
- Demand-Side Dynamics: Category II Exposure growth in China vs. Category III Exposure potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
India
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Human Rabies Immunoglobulin (IM) market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., HRIG in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Category III Exposure in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., ERIG dominance in Europe vs. HRIG demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure. Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization. In this report, we study ERIG (Equine Rabies Immunoglobulin) and HRIG (Human Rabies Immunoglobulin)
The rising incidence of rabies, especially in developing countries, is a key driver of the human rabies immunoglobulin market. Rabies remains a significant public health concern, particularly in regions where animal vaccination programs are insufficient. Post-exposure prophylaxis (PEP), which includes human rabies immunoglobulin, is critical for preventing the virus after a bite from a rabid animal. Increasing awareness of rabies prevention, government initiatives, and partnerships with international health organizations have boosted demand for human rabies immunoglobulin in both rural and urban areas.
A major challenge in the human rabies immunoglobulin market is its limited availability and high cost, particularly in low- and middle-income countries where rabies is most prevalent. The production of immunoglobulins requires advanced technology and biological materials, making it costly and sometimes scarce in regions with insufficient healthcare infrastructure. Additionally, the need for timely administration after exposure poses logistical difficulties, especially in remote areas, where access to healthcare facilities may be delayed, potentially limiting the effectiveness of the treatment.
Asia-Pacific is expected to experience the highest growth in the market during the forecast period.
The global Human Rabies Immunoglobulin (IM) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
CSL Behring
Grifols
Sanofi
Sichuan Yuanda Shuyang
Tiantan Bio
Kamada
CBPO
Shuanglin Bio
Weiguang Bio
Shanghai RAAS
Bharat Serum
VINS
By Type: (Dominant Segment vs High-Margin Innovation)
ERIG
HRIG
By Application: (Core Demand Driver vs Emerging Opportunity)
Category II Exposure
Category III Exposure
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., CSL Behring in Europe)
- Emerging Product Trends: ERIG adoption vs. HRIG premiumization
- Demand-Side Dynamics: Category II Exposure growth in China vs. Category III Exposure potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
India
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Human Rabies Immunoglobulin (IM) market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., HRIG in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Category III Exposure in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., ERIG dominance in Europe vs. HRIG demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Human Rabies Immunoglobulin (IM) Product Scope
1.2 Human Rabies Immunoglobulin (IM) by Type
1.2.1 Global Human Rabies Immunoglobulin (IM) Sales by Type (2020 & 2024 & 2031)
1.2.2 ERIG
1.2.3 HRIG
1.3 Human Rabies Immunoglobulin (IM) by Application
1.3.1 Global Human Rabies Immunoglobulin (IM) Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Global Human Rabies Immunoglobulin (IM) Market Estimates and Forecasts (2020-2031)
1.4.1 Global Human Rabies Immunoglobulin (IM) Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Human Rabies Immunoglobulin (IM) Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Human Rabies Immunoglobulin (IM) Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Human Rabies Immunoglobulin (IM) Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Human Rabies Immunoglobulin (IM) Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2020-2025)
2.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2020-2025)
2.3 Global Human Rabies Immunoglobulin (IM) Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Human Rabies Immunoglobulin (IM) Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Human Rabies Immunoglobulin (IM) Market Size and Prospective (2020-2031)
2.4.2 Europe Human Rabies Immunoglobulin (IM) Market Size and Prospective (2020-2031)
2.4.3 China Human Rabies Immunoglobulin (IM) Market Size and Prospective (2020-2031)
2.4.4 India Human Rabies Immunoglobulin (IM) Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Human Rabies Immunoglobulin (IM) Historic Market Review by Type (2020-2025)
3.1.1 Global Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025)
3.1.2 Global Human Rabies Immunoglobulin (IM) Revenue by Type (2020-2025)
3.1.3 Global Human Rabies Immunoglobulin (IM) Price by Type (2020-2025)
3.2 Global Human Rabies Immunoglobulin (IM) Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Human Rabies Immunoglobulin (IM) Sales Forecast by Type (2026-2031)
3.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Type (2026-2031)
3.2.3 Global Human Rabies Immunoglobulin (IM) Price Forecast by Type (2026-2031)
3.3 Different Types Human Rabies Immunoglobulin (IM) Representative Players
4 Global Market Size by Application
4.1 Global Human Rabies Immunoglobulin (IM) Historic Market Review by Application (2020-2025)
4.1.1 Global Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025)
4.1.2 Global Human Rabies Immunoglobulin (IM) Revenue by Application (2020-2025)
4.1.3 Global Human Rabies Immunoglobulin (IM) Price by Application (2020-2025)
4.2 Global Human Rabies Immunoglobulin (IM) Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Human Rabies Immunoglobulin (IM) Sales Forecast by Application (2026-2031)
4.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Application (2026-2031)
4.2.3 Global Human Rabies Immunoglobulin (IM) Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Human Rabies Immunoglobulin (IM) Application
5 Competition Landscape by Players
5.1 Global Human Rabies Immunoglobulin (IM) Sales by Players (2020-2025)
5.2 Global Top Human Rabies Immunoglobulin (IM) Players by Revenue (2020-2025)
5.3 Global Human Rabies Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rabies Immunoglobulin (IM) as of 2024)
5.4 Global Human Rabies Immunoglobulin (IM) Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Human Rabies Immunoglobulin (IM), Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Human Rabies Immunoglobulin (IM), Product Type & Application
5.7 Global Key Manufacturers of Human Rabies Immunoglobulin (IM), Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Human Rabies Immunoglobulin (IM) Sales by Company
6.1.1.1 North America Human Rabies Immunoglobulin (IM) Sales by Company (2020-2025)
6.1.1.2 North America Human Rabies Immunoglobulin (IM) Revenue by Company (2020-2025)
6.1.2 North America Human Rabies Immunoglobulin (IM) Sales Breakdown by Type (2020-2025)
6.1.3 North America Human Rabies Immunoglobulin (IM) Sales Breakdown by Application (2020-2025)
6.1.4 North America Human Rabies Immunoglobulin (IM) Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Human Rabies Immunoglobulin (IM) Sales by Company
6.2.1.1 Europe Human Rabies Immunoglobulin (IM) Sales by Company (2020-2025)
6.2.1.2 Europe Human Rabies Immunoglobulin (IM) Revenue by Company (2020-2025)
6.2.2 Europe Human Rabies Immunoglobulin (IM) Sales Breakdown by Type (2020-2025)
6.2.3 Europe Human Rabies Immunoglobulin (IM) Sales Breakdown by Application (2020-2025)
6.2.4 Europe Human Rabies Immunoglobulin (IM) Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Human Rabies Immunoglobulin (IM) Sales by Company
6.3.1.1 China Human Rabies Immunoglobulin (IM) Sales by Company (2020-2025)
6.3.1.2 China Human Rabies Immunoglobulin (IM) Revenue by Company (2020-2025)
6.3.2 China Human Rabies Immunoglobulin (IM) Sales Breakdown by Type (2020-2025)
6.3.3 China Human Rabies Immunoglobulin (IM) Sales Breakdown by Application (2020-2025)
6.3.4 China Human Rabies Immunoglobulin (IM) Major Customer
6.3.5 China Market Trend and Opportunities
6.4 India Market: Players, Segments, Downstream and Major Customers
6.4.1 India Human Rabies Immunoglobulin (IM) Sales by Company
6.4.1.1 India Human Rabies Immunoglobulin (IM) Sales by Company (2020-2025)
6.4.1.2 India Human Rabies Immunoglobulin (IM) Revenue by Company (2020-2025)
6.4.2 India Human Rabies Immunoglobulin (IM) Sales Breakdown by Type (2020-2025)
6.4.3 India Human Rabies Immunoglobulin (IM) Sales Breakdown by Application (2020-2025)
6.4.4 India Human Rabies Immunoglobulin (IM) Major Customer
6.4.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 CSL Behring
7.1.1 CSL Behring Company Information
7.1.2 CSL Behring Business Overview
7.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
7.1.4 CSL Behring Human Rabies Immunoglobulin (IM) Products Offered
7.1.5 CSL Behring Recent Development
7.2 Grifols
7.2.1 Grifols Company Information
7.2.2 Grifols Business Overview
7.2.3 Grifols Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Grifols Human Rabies Immunoglobulin (IM) Products Offered
7.2.5 Grifols Recent Development
7.3 Sanofi
7.3.1 Sanofi Company Information
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Sanofi Human Rabies Immunoglobulin (IM) Products Offered
7.3.5 Sanofi Recent Development
7.4 Sichuan Yuanda Shuyang
7.4.1 Sichuan Yuanda Shuyang Company Information
7.4.2 Sichuan Yuanda Shuyang Business Overview
7.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Products Offered
7.4.5 Sichuan Yuanda Shuyang Recent Development
7.5 Tiantan Bio
7.5.1 Tiantan Bio Company Information
7.5.2 Tiantan Bio Business Overview
7.5.3 Tiantan Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Tiantan Bio Human Rabies Immunoglobulin (IM) Products Offered
7.5.5 Tiantan Bio Recent Development
7.6 Kamada
7.6.1 Kamada Company Information
7.6.2 Kamada Business Overview
7.6.3 Kamada Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Kamada Human Rabies Immunoglobulin (IM) Products Offered
7.6.5 Kamada Recent Development
7.7 CBPO
7.7.1 CBPO Company Information
7.7.2 CBPO Business Overview
7.7.3 CBPO Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
7.7.4 CBPO Human Rabies Immunoglobulin (IM) Products Offered
7.7.5 CBPO Recent Development
7.8 Shuanglin Bio
7.8.1 Shuanglin Bio Company Information
7.8.2 Shuanglin Bio Business Overview
7.8.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Shuanglin Bio Human Rabies Immunoglobulin (IM) Products Offered
7.8.5 Shuanglin Bio Recent Development
7.9 Weiguang Bio
7.9.1 Weiguang Bio Company Information
7.9.2 Weiguang Bio Business Overview
7.9.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Weiguang Bio Human Rabies Immunoglobulin (IM) Products Offered
7.9.5 Weiguang Bio Recent Development
7.10 Shanghai RAAS
7.10.1 Shanghai RAAS Company Information
7.10.2 Shanghai RAAS Business Overview
7.10.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Shanghai RAAS Human Rabies Immunoglobulin (IM) Products Offered
7.10.5 Shanghai RAAS Recent Development
7.11 Bharat Serum
7.11.1 Bharat Serum Company Information
7.11.2 Bharat Serum Business Overview
7.11.3 Bharat Serum Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Bharat Serum Human Rabies Immunoglobulin (IM) Products Offered
7.11.5 Bharat Serum Recent Development
7.12 VINS
7.12.1 VINS Company Information
7.12.2 VINS Business Overview
7.12.3 VINS Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
7.12.4 VINS Human Rabies Immunoglobulin (IM) Products Offered
7.12.5 VINS Recent Development
8 Human Rabies Immunoglobulin (IM) Manufacturing Cost Analysis
8.1 Human Rabies Immunoglobulin (IM) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Human Rabies Immunoglobulin (IM)
8.4 Human Rabies Immunoglobulin (IM) Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Human Rabies Immunoglobulin (IM) Distributors List
9.3 Human Rabies Immunoglobulin (IM) Customers
10 Human Rabies Immunoglobulin (IM) Market Dynamics
10.1 Human Rabies Immunoglobulin (IM) Industry Trends
10.2 Human Rabies Immunoglobulin (IM) Market Drivers
10.3 Human Rabies Immunoglobulin (IM) Market Challenges
10.4 Human Rabies Immunoglobulin (IM) Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Human Rabies Immunoglobulin (IM) Product Scope
1.2 Human Rabies Immunoglobulin (IM) by Type
1.2.1 Global Human Rabies Immunoglobulin (IM) Sales by Type (2020 & 2024 & 2031)
1.2.2 ERIG
1.2.3 HRIG
1.3 Human Rabies Immunoglobulin (IM) by Application
1.3.1 Global Human Rabies Immunoglobulin (IM) Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Global Human Rabies Immunoglobulin (IM) Market Estimates and Forecasts (2020-2031)
1.4.1 Global Human Rabies Immunoglobulin (IM) Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Human Rabies Immunoglobulin (IM) Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Human Rabies Immunoglobulin (IM) Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Human Rabies Immunoglobulin (IM) Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Human Rabies Immunoglobulin (IM) Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2020-2025)
2.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2020-2025)
2.3 Global Human Rabies Immunoglobulin (IM) Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Human Rabies Immunoglobulin (IM) Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Human Rabies Immunoglobulin (IM) Market Size and Prospective (2020-2031)
2.4.2 Europe Human Rabies Immunoglobulin (IM) Market Size and Prospective (2020-2031)
2.4.3 China Human Rabies Immunoglobulin (IM) Market Size and Prospective (2020-2031)
2.4.4 India Human Rabies Immunoglobulin (IM) Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Human Rabies Immunoglobulin (IM) Historic Market Review by Type (2020-2025)
3.1.1 Global Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025)
3.1.2 Global Human Rabies Immunoglobulin (IM) Revenue by Type (2020-2025)
3.1.3 Global Human Rabies Immunoglobulin (IM) Price by Type (2020-2025)
3.2 Global Human Rabies Immunoglobulin (IM) Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Human Rabies Immunoglobulin (IM) Sales Forecast by Type (2026-2031)
3.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Type (2026-2031)
3.2.3 Global Human Rabies Immunoglobulin (IM) Price Forecast by Type (2026-2031)
3.3 Different Types Human Rabies Immunoglobulin (IM) Representative Players
4 Global Market Size by Application
4.1 Global Human Rabies Immunoglobulin (IM) Historic Market Review by Application (2020-2025)
4.1.1 Global Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025)
4.1.2 Global Human Rabies Immunoglobulin (IM) Revenue by Application (2020-2025)
4.1.3 Global Human Rabies Immunoglobulin (IM) Price by Application (2020-2025)
4.2 Global Human Rabies Immunoglobulin (IM) Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Human Rabies Immunoglobulin (IM) Sales Forecast by Application (2026-2031)
4.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Forecast by Application (2026-2031)
4.2.3 Global Human Rabies Immunoglobulin (IM) Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Human Rabies Immunoglobulin (IM) Application
5 Competition Landscape by Players
5.1 Global Human Rabies Immunoglobulin (IM) Sales by Players (2020-2025)
5.2 Global Top Human Rabies Immunoglobulin (IM) Players by Revenue (2020-2025)
5.3 Global Human Rabies Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rabies Immunoglobulin (IM) as of 2024)
5.4 Global Human Rabies Immunoglobulin (IM) Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Human Rabies Immunoglobulin (IM), Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Human Rabies Immunoglobulin (IM), Product Type & Application
5.7 Global Key Manufacturers of Human Rabies Immunoglobulin (IM), Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Human Rabies Immunoglobulin (IM) Sales by Company
6.1.1.1 North America Human Rabies Immunoglobulin (IM) Sales by Company (2020-2025)
6.1.1.2 North America Human Rabies Immunoglobulin (IM) Revenue by Company (2020-2025)
6.1.2 North America Human Rabies Immunoglobulin (IM) Sales Breakdown by Type (2020-2025)
6.1.3 North America Human Rabies Immunoglobulin (IM) Sales Breakdown by Application (2020-2025)
6.1.4 North America Human Rabies Immunoglobulin (IM) Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Human Rabies Immunoglobulin (IM) Sales by Company
6.2.1.1 Europe Human Rabies Immunoglobulin (IM) Sales by Company (2020-2025)
6.2.1.2 Europe Human Rabies Immunoglobulin (IM) Revenue by Company (2020-2025)
6.2.2 Europe Human Rabies Immunoglobulin (IM) Sales Breakdown by Type (2020-2025)
6.2.3 Europe Human Rabies Immunoglobulin (IM) Sales Breakdown by Application (2020-2025)
6.2.4 Europe Human Rabies Immunoglobulin (IM) Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Human Rabies Immunoglobulin (IM) Sales by Company
6.3.1.1 China Human Rabies Immunoglobulin (IM) Sales by Company (2020-2025)
6.3.1.2 China Human Rabies Immunoglobulin (IM) Revenue by Company (2020-2025)
6.3.2 China Human Rabies Immunoglobulin (IM) Sales Breakdown by Type (2020-2025)
6.3.3 China Human Rabies Immunoglobulin (IM) Sales Breakdown by Application (2020-2025)
6.3.4 China Human Rabies Immunoglobulin (IM) Major Customer
6.3.5 China Market Trend and Opportunities
6.4 India Market: Players, Segments, Downstream and Major Customers
6.4.1 India Human Rabies Immunoglobulin (IM) Sales by Company
6.4.1.1 India Human Rabies Immunoglobulin (IM) Sales by Company (2020-2025)
6.4.1.2 India Human Rabies Immunoglobulin (IM) Revenue by Company (2020-2025)
6.4.2 India Human Rabies Immunoglobulin (IM) Sales Breakdown by Type (2020-2025)
6.4.3 India Human Rabies Immunoglobulin (IM) Sales Breakdown by Application (2020-2025)
6.4.4 India Human Rabies Immunoglobulin (IM) Major Customer
6.4.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 CSL Behring
7.1.1 CSL Behring Company Information
7.1.2 CSL Behring Business Overview
7.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
7.1.4 CSL Behring Human Rabies Immunoglobulin (IM) Products Offered
7.1.5 CSL Behring Recent Development
7.2 Grifols
7.2.1 Grifols Company Information
7.2.2 Grifols Business Overview
7.2.3 Grifols Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Grifols Human Rabies Immunoglobulin (IM) Products Offered
7.2.5 Grifols Recent Development
7.3 Sanofi
7.3.1 Sanofi Company Information
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Sanofi Human Rabies Immunoglobulin (IM) Products Offered
7.3.5 Sanofi Recent Development
7.4 Sichuan Yuanda Shuyang
7.4.1 Sichuan Yuanda Shuyang Company Information
7.4.2 Sichuan Yuanda Shuyang Business Overview
7.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Products Offered
7.4.5 Sichuan Yuanda Shuyang Recent Development
7.5 Tiantan Bio
7.5.1 Tiantan Bio Company Information
7.5.2 Tiantan Bio Business Overview
7.5.3 Tiantan Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Tiantan Bio Human Rabies Immunoglobulin (IM) Products Offered
7.5.5 Tiantan Bio Recent Development
7.6 Kamada
7.6.1 Kamada Company Information
7.6.2 Kamada Business Overview
7.6.3 Kamada Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Kamada Human Rabies Immunoglobulin (IM) Products Offered
7.6.5 Kamada Recent Development
7.7 CBPO
7.7.1 CBPO Company Information
7.7.2 CBPO Business Overview
7.7.3 CBPO Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
7.7.4 CBPO Human Rabies Immunoglobulin (IM) Products Offered
7.7.5 CBPO Recent Development
7.8 Shuanglin Bio
7.8.1 Shuanglin Bio Company Information
7.8.2 Shuanglin Bio Business Overview
7.8.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Shuanglin Bio Human Rabies Immunoglobulin (IM) Products Offered
7.8.5 Shuanglin Bio Recent Development
7.9 Weiguang Bio
7.9.1 Weiguang Bio Company Information
7.9.2 Weiguang Bio Business Overview
7.9.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Weiguang Bio Human Rabies Immunoglobulin (IM) Products Offered
7.9.5 Weiguang Bio Recent Development
7.10 Shanghai RAAS
7.10.1 Shanghai RAAS Company Information
7.10.2 Shanghai RAAS Business Overview
7.10.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Shanghai RAAS Human Rabies Immunoglobulin (IM) Products Offered
7.10.5 Shanghai RAAS Recent Development
7.11 Bharat Serum
7.11.1 Bharat Serum Company Information
7.11.2 Bharat Serum Business Overview
7.11.3 Bharat Serum Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Bharat Serum Human Rabies Immunoglobulin (IM) Products Offered
7.11.5 Bharat Serum Recent Development
7.12 VINS
7.12.1 VINS Company Information
7.12.2 VINS Business Overview
7.12.3 VINS Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2020-2025)
7.12.4 VINS Human Rabies Immunoglobulin (IM) Products Offered
7.12.5 VINS Recent Development
8 Human Rabies Immunoglobulin (IM) Manufacturing Cost Analysis
8.1 Human Rabies Immunoglobulin (IM) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Human Rabies Immunoglobulin (IM)
8.4 Human Rabies Immunoglobulin (IM) Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Human Rabies Immunoglobulin (IM) Distributors List
9.3 Human Rabies Immunoglobulin (IM) Customers
10 Human Rabies Immunoglobulin (IM) Market Dynamics
10.1 Human Rabies Immunoglobulin (IM) Industry Trends
10.2 Human Rabies Immunoglobulin (IM) Market Drivers
10.3 Human Rabies Immunoglobulin (IM) Market Challenges
10.4 Human Rabies Immunoglobulin (IM) Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Human Rabies Immunoglobulin (IM) Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Human Rabies Immunoglobulin (IM) Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Human Rabies Immunoglobulin (IM) Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Human Rabies Immunoglobulin (IM) Sales (K Units) by Region (2020-2025)
Table 5. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2020-2025)
Table 6. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Human Rabies Immunoglobulin (IM) Revenue Share by Region (2020-2025)
Table 8. Global Human Rabies Immunoglobulin (IM) Sales (K Units) Forecast by Region (2026-2031)
Table 9. Global Human Rabies Immunoglobulin (IM) Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Human Rabies Immunoglobulin (IM) Revenue Share Forecast by Region (2026-2031)
Table 12. Global Human Rabies Immunoglobulin (IM) Sales by Type (K Units) & (2020-2025)
Table 13. Global Human Rabies Immunoglobulin (IM) Sales Share by Type (2020-2025)
Table 14. Global Human Rabies Immunoglobulin (IM) Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Human Rabies Immunoglobulin (IM) Price by Type (US$/Unit) & (2020-2025)
Table 16. Global Human Rabies Immunoglobulin (IM) Sales by Type (K Units) & (2026-2031)
Table 17. Global Human Rabies Immunoglobulin (IM) Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Human Rabies Immunoglobulin (IM) Price by Type (US$/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Human Rabies Immunoglobulin (IM) Sales by Application (K Units) & (2020-2025)
Table 21. Global Human Rabies Immunoglobulin (IM) Sales Share by Application (2020-2025)
Table 22. Global Human Rabies Immunoglobulin (IM) Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Human Rabies Immunoglobulin (IM) Price by Application (US$/Unit) & (2020-2025)
Table 24. Global Human Rabies Immunoglobulin (IM) Sales by Application (K Units) & (2026-2031)
Table 25. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Human Rabies Immunoglobulin (IM) Price by Application (US$/Unit) & (2026-2031)
Table 27. New Sources of Growth in Human Rabies Immunoglobulin (IM) Application
Table 28. Global Human Rabies Immunoglobulin (IM) Sales by Company (K Units) & (2020-2025)
Table 29. Global Human Rabies Immunoglobulin (IM) Sales Share by Company (2020-2025)
Table 30. Global Human Rabies Immunoglobulin (IM) Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Human Rabies Immunoglobulin (IM) Revenue Share by Company (2020-2025)
Table 32. Global Human Rabies Immunoglobulin (IM) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rabies Immunoglobulin (IM) as of 2024)
Table 33. Global Market Human Rabies Immunoglobulin (IM) Average Price by Company (US$/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Human Rabies Immunoglobulin (IM), Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Human Rabies Immunoglobulin (IM), Product Type & Application
Table 36. Global Key Manufacturers of Human Rabies Immunoglobulin (IM), Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Human Rabies Immunoglobulin (IM) Sales by Company (2020-2025) & (K Units)
Table 39. North America Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2020-2025)
Table 40. North America Human Rabies Immunoglobulin (IM) Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Human Rabies Immunoglobulin (IM) Revenue Market Share by Company (2020-2025)
Table 42. North America Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 43. North America Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Table 44. North America Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 45. North America Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Table 46. Europe Human Rabies Immunoglobulin (IM) Sales by Company (2020-2025) & (K Units)
Table 47. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2020-2025)
Table 48. Europe Human Rabies Immunoglobulin (IM) Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Human Rabies Immunoglobulin (IM) Revenue Market Share by Company (2020-2025)
Table 50. Europe Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 51. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Table 52. Europe Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 53. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Table 54. China Human Rabies Immunoglobulin (IM) Sales by Company (2020-2025) & (K Units)
Table 55. China Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2020-2025)
Table 56. China Human Rabies Immunoglobulin (IM) Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Human Rabies Immunoglobulin (IM) Revenue Market Share by Company (2020-2025)
Table 58. China Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 59. China Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Table 60. China Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 61. China Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Table 62. India Human Rabies Immunoglobulin (IM) Sales by Company (2020-2025) & (K Units)
Table 63. India Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2020-2025)
Table 64. India Human Rabies Immunoglobulin (IM) Revenue by Company (2020-2025) & (US$ Million)
Table 65. India Human Rabies Immunoglobulin (IM) Revenue Market Share by Company (2020-2025)
Table 66. India Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 67. India Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Table 68. India Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 69. India Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Table 70. CSL Behring Company Information
Table 71. CSL Behring Description and Business Overview
Table 72. CSL Behring Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. CSL Behring Human Rabies Immunoglobulin (IM) Product
Table 74. CSL Behring Recent Development
Table 75. Grifols Company Information
Table 76. Grifols Description and Business Overview
Table 77. Grifols Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Grifols Human Rabies Immunoglobulin (IM) Product
Table 79. Grifols Recent Development
Table 80. Sanofi Company Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Sanofi Human Rabies Immunoglobulin (IM) Product
Table 84. Sanofi Recent Development
Table 85. Sichuan Yuanda Shuyang Company Information
Table 86. Sichuan Yuanda Shuyang Description and Business Overview
Table 87. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product
Table 89. Sichuan Yuanda Shuyang Recent Development
Table 90. Tiantan Bio Company Information
Table 91. Tiantan Bio Description and Business Overview
Table 92. Tiantan Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Tiantan Bio Human Rabies Immunoglobulin (IM) Product
Table 94. Tiantan Bio Recent Development
Table 95. Kamada Company Information
Table 96. Kamada Description and Business Overview
Table 97. Kamada Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Kamada Human Rabies Immunoglobulin (IM) Product
Table 99. Kamada Recent Development
Table 100. CBPO Company Information
Table 101. CBPO Description and Business Overview
Table 102. CBPO Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. CBPO Human Rabies Immunoglobulin (IM) Product
Table 104. CBPO Recent Development
Table 105. Shuanglin Bio Company Information
Table 106. Shuanglin Bio Description and Business Overview
Table 107. Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Shuanglin Bio Human Rabies Immunoglobulin (IM) Product
Table 109. Shuanglin Bio Recent Development
Table 110. Weiguang Bio Company Information
Table 111. Weiguang Bio Description and Business Overview
Table 112. Weiguang Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Weiguang Bio Human Rabies Immunoglobulin (IM) Product
Table 114. Weiguang Bio Recent Development
Table 115. Shanghai RAAS Company Information
Table 116. Shanghai RAAS Description and Business Overview
Table 117. Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Shanghai RAAS Human Rabies Immunoglobulin (IM) Product
Table 119. Shanghai RAAS Recent Development
Table 120. Bharat Serum Company Information
Table 121. Bharat Serum Description and Business Overview
Table 122. Bharat Serum Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Bharat Serum Human Rabies Immunoglobulin (IM) Product
Table 124. Bharat Serum Recent Development
Table 125. VINS Company Information
Table 126. VINS Description and Business Overview
Table 127. VINS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. VINS Human Rabies Immunoglobulin (IM) Product
Table 129. VINS Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Human Rabies Immunoglobulin (IM) Distributors List
Table 133. Human Rabies Immunoglobulin (IM) Customers List
Table 134. Human Rabies Immunoglobulin (IM) Market Trends
Table 135. Human Rabies Immunoglobulin (IM) Market Drivers
Table 136. Human Rabies Immunoglobulin (IM) Market Challenges
Table 137. Human Rabies Immunoglobulin (IM) Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Rabies Immunoglobulin (IM) Product Picture
Figure 2. Global Human Rabies Immunoglobulin (IM) Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type in 2024 & 2031
Figure 4. ERIG Product Picture
Figure 5. HRIG Product Picture
Figure 6. Global Human Rabies Immunoglobulin (IM) Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application in 2024 & 2031
Figure 8. Category II Exposure Examples
Figure 9. Category III Exposure Examples
Figure 10. Global Human Rabies Immunoglobulin (IM) Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Human Rabies Immunoglobulin (IM) Sales Growth Rate (2020-2031) & (US$ Million)
Figure 12. Global Human Rabies Immunoglobulin (IM) Sales (K Units) Growth Rate (2020-2031)
Figure 13. Global Human Rabies Immunoglobulin (IM) Price Trends Growth Rate (2020-2031) & (US$/Unit)
Figure 14. Human Rabies Immunoglobulin (IM) Report Years Considered
Figure 15. Global Market Human Rabies Immunoglobulin (IM) Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 16. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region: 2020 VS 2024
Figure 17. North America Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. North America Human Rabies Immunoglobulin (IM) Sales (K Units) Growth Rate (2020-2031)
Figure 19. Europe Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Europe Human Rabies Immunoglobulin (IM) Sales (K Units) Growth Rate (2020-2031)
Figure 21. China Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. China Human Rabies Immunoglobulin (IM) Sales (K Units) Growth Rate (2020-2031)
Figure 23. India Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. India Human Rabies Immunoglobulin (IM) Sales (K Units) Growth Rate (2020-2031)
Figure 25. Global Human Rabies Immunoglobulin (IM) Revenue Share by Type (2020-2025)
Figure 26. Global Human Rabies Immunoglobulin (IM) Sales Share by Type (2026-2031)
Figure 27. Global Human Rabies Immunoglobulin (IM) Revenue Share by Type (2026-2031)
Figure 28. Global Human Rabies Immunoglobulin (IM) Revenue Share by Application (2020-2025)
Figure 29. Global Human Rabies Immunoglobulin (IM) Revenue Growth Rate by Application in 2020 & 2024
Figure 30. Global Human Rabies Immunoglobulin (IM) Sales Share by Application (2026-2031)
Figure 31. Global Human Rabies Immunoglobulin (IM) Revenue Share by Application (2026-2031)
Figure 32. Global Human Rabies Immunoglobulin (IM) Sales Share by Company (2024)
Figure 33. Global Human Rabies Immunoglobulin (IM) Revenue Share by Company (2024)
Figure 34. Global 5 Largest Human Rabies Immunoglobulin (IM) Players Market Share by Revenue in Human Rabies Immunoglobulin (IM): 2020 & 2024
Figure 35. Human Rabies Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 36. Manufacturing Cost Structure of Human Rabies Immunoglobulin (IM)
Figure 37. Manufacturing Process Analysis of Human Rabies Immunoglobulin (IM)
Figure 38. Human Rabies Immunoglobulin (IM) Industrial Chain
Figure 39. Channels of Distribution (Direct Vs Distribution)
Figure 40. Distributors Profiles
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
Table 1. Global Human Rabies Immunoglobulin (IM) Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Human Rabies Immunoglobulin (IM) Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Human Rabies Immunoglobulin (IM) Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Human Rabies Immunoglobulin (IM) Sales (K Units) by Region (2020-2025)
Table 5. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2020-2025)
Table 6. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Human Rabies Immunoglobulin (IM) Revenue Share by Region (2020-2025)
Table 8. Global Human Rabies Immunoglobulin (IM) Sales (K Units) Forecast by Region (2026-2031)
Table 9. Global Human Rabies Immunoglobulin (IM) Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Human Rabies Immunoglobulin (IM) Revenue Share Forecast by Region (2026-2031)
Table 12. Global Human Rabies Immunoglobulin (IM) Sales by Type (K Units) & (2020-2025)
Table 13. Global Human Rabies Immunoglobulin (IM) Sales Share by Type (2020-2025)
Table 14. Global Human Rabies Immunoglobulin (IM) Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Human Rabies Immunoglobulin (IM) Price by Type (US$/Unit) & (2020-2025)
Table 16. Global Human Rabies Immunoglobulin (IM) Sales by Type (K Units) & (2026-2031)
Table 17. Global Human Rabies Immunoglobulin (IM) Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Human Rabies Immunoglobulin (IM) Price by Type (US$/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Human Rabies Immunoglobulin (IM) Sales by Application (K Units) & (2020-2025)
Table 21. Global Human Rabies Immunoglobulin (IM) Sales Share by Application (2020-2025)
Table 22. Global Human Rabies Immunoglobulin (IM) Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Human Rabies Immunoglobulin (IM) Price by Application (US$/Unit) & (2020-2025)
Table 24. Global Human Rabies Immunoglobulin (IM) Sales by Application (K Units) & (2026-2031)
Table 25. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Human Rabies Immunoglobulin (IM) Price by Application (US$/Unit) & (2026-2031)
Table 27. New Sources of Growth in Human Rabies Immunoglobulin (IM) Application
Table 28. Global Human Rabies Immunoglobulin (IM) Sales by Company (K Units) & (2020-2025)
Table 29. Global Human Rabies Immunoglobulin (IM) Sales Share by Company (2020-2025)
Table 30. Global Human Rabies Immunoglobulin (IM) Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Human Rabies Immunoglobulin (IM) Revenue Share by Company (2020-2025)
Table 32. Global Human Rabies Immunoglobulin (IM) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rabies Immunoglobulin (IM) as of 2024)
Table 33. Global Market Human Rabies Immunoglobulin (IM) Average Price by Company (US$/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Human Rabies Immunoglobulin (IM), Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Human Rabies Immunoglobulin (IM), Product Type & Application
Table 36. Global Key Manufacturers of Human Rabies Immunoglobulin (IM), Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Human Rabies Immunoglobulin (IM) Sales by Company (2020-2025) & (K Units)
Table 39. North America Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2020-2025)
Table 40. North America Human Rabies Immunoglobulin (IM) Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Human Rabies Immunoglobulin (IM) Revenue Market Share by Company (2020-2025)
Table 42. North America Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 43. North America Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Table 44. North America Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 45. North America Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Table 46. Europe Human Rabies Immunoglobulin (IM) Sales by Company (2020-2025) & (K Units)
Table 47. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2020-2025)
Table 48. Europe Human Rabies Immunoglobulin (IM) Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Human Rabies Immunoglobulin (IM) Revenue Market Share by Company (2020-2025)
Table 50. Europe Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 51. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Table 52. Europe Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 53. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Table 54. China Human Rabies Immunoglobulin (IM) Sales by Company (2020-2025) & (K Units)
Table 55. China Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2020-2025)
Table 56. China Human Rabies Immunoglobulin (IM) Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Human Rabies Immunoglobulin (IM) Revenue Market Share by Company (2020-2025)
Table 58. China Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 59. China Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Table 60. China Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 61. China Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Table 62. India Human Rabies Immunoglobulin (IM) Sales by Company (2020-2025) & (K Units)
Table 63. India Human Rabies Immunoglobulin (IM) Sales Market Share by Company (2020-2025)
Table 64. India Human Rabies Immunoglobulin (IM) Revenue by Company (2020-2025) & (US$ Million)
Table 65. India Human Rabies Immunoglobulin (IM) Revenue Market Share by Company (2020-2025)
Table 66. India Human Rabies Immunoglobulin (IM) Sales by Type (2020-2025) & (K Units)
Table 67. India Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2020-2025)
Table 68. India Human Rabies Immunoglobulin (IM) Sales by Application (2020-2025) & (K Units)
Table 69. India Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2020-2025)
Table 70. CSL Behring Company Information
Table 71. CSL Behring Description and Business Overview
Table 72. CSL Behring Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. CSL Behring Human Rabies Immunoglobulin (IM) Product
Table 74. CSL Behring Recent Development
Table 75. Grifols Company Information
Table 76. Grifols Description and Business Overview
Table 77. Grifols Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Grifols Human Rabies Immunoglobulin (IM) Product
Table 79. Grifols Recent Development
Table 80. Sanofi Company Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Sanofi Human Rabies Immunoglobulin (IM) Product
Table 84. Sanofi Recent Development
Table 85. Sichuan Yuanda Shuyang Company Information
Table 86. Sichuan Yuanda Shuyang Description and Business Overview
Table 87. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product
Table 89. Sichuan Yuanda Shuyang Recent Development
Table 90. Tiantan Bio Company Information
Table 91. Tiantan Bio Description and Business Overview
Table 92. Tiantan Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Tiantan Bio Human Rabies Immunoglobulin (IM) Product
Table 94. Tiantan Bio Recent Development
Table 95. Kamada Company Information
Table 96. Kamada Description and Business Overview
Table 97. Kamada Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Kamada Human Rabies Immunoglobulin (IM) Product
Table 99. Kamada Recent Development
Table 100. CBPO Company Information
Table 101. CBPO Description and Business Overview
Table 102. CBPO Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. CBPO Human Rabies Immunoglobulin (IM) Product
Table 104. CBPO Recent Development
Table 105. Shuanglin Bio Company Information
Table 106. Shuanglin Bio Description and Business Overview
Table 107. Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Shuanglin Bio Human Rabies Immunoglobulin (IM) Product
Table 109. Shuanglin Bio Recent Development
Table 110. Weiguang Bio Company Information
Table 111. Weiguang Bio Description and Business Overview
Table 112. Weiguang Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Weiguang Bio Human Rabies Immunoglobulin (IM) Product
Table 114. Weiguang Bio Recent Development
Table 115. Shanghai RAAS Company Information
Table 116. Shanghai RAAS Description and Business Overview
Table 117. Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Shanghai RAAS Human Rabies Immunoglobulin (IM) Product
Table 119. Shanghai RAAS Recent Development
Table 120. Bharat Serum Company Information
Table 121. Bharat Serum Description and Business Overview
Table 122. Bharat Serum Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Bharat Serum Human Rabies Immunoglobulin (IM) Product
Table 124. Bharat Serum Recent Development
Table 125. VINS Company Information
Table 126. VINS Description and Business Overview
Table 127. VINS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. VINS Human Rabies Immunoglobulin (IM) Product
Table 129. VINS Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Human Rabies Immunoglobulin (IM) Distributors List
Table 133. Human Rabies Immunoglobulin (IM) Customers List
Table 134. Human Rabies Immunoglobulin (IM) Market Trends
Table 135. Human Rabies Immunoglobulin (IM) Market Drivers
Table 136. Human Rabies Immunoglobulin (IM) Market Challenges
Table 137. Human Rabies Immunoglobulin (IM) Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Rabies Immunoglobulin (IM) Product Picture
Figure 2. Global Human Rabies Immunoglobulin (IM) Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type in 2024 & 2031
Figure 4. ERIG Product Picture
Figure 5. HRIG Product Picture
Figure 6. Global Human Rabies Immunoglobulin (IM) Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application in 2024 & 2031
Figure 8. Category II Exposure Examples
Figure 9. Category III Exposure Examples
Figure 10. Global Human Rabies Immunoglobulin (IM) Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Human Rabies Immunoglobulin (IM) Sales Growth Rate (2020-2031) & (US$ Million)
Figure 12. Global Human Rabies Immunoglobulin (IM) Sales (K Units) Growth Rate (2020-2031)
Figure 13. Global Human Rabies Immunoglobulin (IM) Price Trends Growth Rate (2020-2031) & (US$/Unit)
Figure 14. Human Rabies Immunoglobulin (IM) Report Years Considered
Figure 15. Global Market Human Rabies Immunoglobulin (IM) Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 16. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region: 2020 VS 2024
Figure 17. North America Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. North America Human Rabies Immunoglobulin (IM) Sales (K Units) Growth Rate (2020-2031)
Figure 19. Europe Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Europe Human Rabies Immunoglobulin (IM) Sales (K Units) Growth Rate (2020-2031)
Figure 21. China Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. China Human Rabies Immunoglobulin (IM) Sales (K Units) Growth Rate (2020-2031)
Figure 23. India Human Rabies Immunoglobulin (IM) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. India Human Rabies Immunoglobulin (IM) Sales (K Units) Growth Rate (2020-2031)
Figure 25. Global Human Rabies Immunoglobulin (IM) Revenue Share by Type (2020-2025)
Figure 26. Global Human Rabies Immunoglobulin (IM) Sales Share by Type (2026-2031)
Figure 27. Global Human Rabies Immunoglobulin (IM) Revenue Share by Type (2026-2031)
Figure 28. Global Human Rabies Immunoglobulin (IM) Revenue Share by Application (2020-2025)
Figure 29. Global Human Rabies Immunoglobulin (IM) Revenue Growth Rate by Application in 2020 & 2024
Figure 30. Global Human Rabies Immunoglobulin (IM) Sales Share by Application (2026-2031)
Figure 31. Global Human Rabies Immunoglobulin (IM) Revenue Share by Application (2026-2031)
Figure 32. Global Human Rabies Immunoglobulin (IM) Sales Share by Company (2024)
Figure 33. Global Human Rabies Immunoglobulin (IM) Revenue Share by Company (2024)
Figure 34. Global 5 Largest Human Rabies Immunoglobulin (IM) Players Market Share by Revenue in Human Rabies Immunoglobulin (IM): 2020 & 2024
Figure 35. Human Rabies Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 36. Manufacturing Cost Structure of Human Rabies Immunoglobulin (IM)
Figure 37. Manufacturing Process Analysis of Human Rabies Immunoglobulin (IM)
Figure 38. Human Rabies Immunoglobulin (IM) Industrial Chain
Figure 39. Channels of Distribution (Direct Vs Distribution)
Figure 40. Distributors Profiles
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232